TABLE 2.
Type of interaction | Particle | Effect | Target | LOD | References |
---|---|---|---|---|---|
Electrostatic interaction | Gold nanoparticle | High rate of bound antibody, but poor orientation | 17β-estradiol | 500 ng/ml | Oliveira et al. (2019) |
Covalent binding | Gold nanoparticle | Lower rate o bound antibody, with good orientation | 17β-estradiol | 200 ng/ml | |
Physical adsorption | Gold nanoparticle | Not available | Erwinia amylovora | 104 CFU/ml | Razo et al. (2021) |
Physical adsorption | Au core—Pt shell nanoparticle | Not available | Erwinia amylovora | 103 CFU/ml | |
Covalent binding | Latex nanoparticle | Not available | Erwinia amylovora | 104 CFU/ml | |
Covalent binding | Magnetic nanoparticle | Not available | Erwinia amylovora | 105 CFU/ml | |
Streptavidin-biotin coupling | Gold nanoparticle | Increased sensitivity for the larger particles (35–50 nm) | Escherichia coli | 101 CFU/ml | You et al. (2020) |
Legionella pneumophila | |||||
Physical adsorption (nanobodies) | Gold nanoparticle | Salt induced aggregation | Not available | Not available | Goossens et al. (2017) |
Physical adsorption | Carbon nanoparticle | Stable conjugates | Influenza A | 3.5 × 102 TCID50 mL−1 | Wiriyachaiporn et al. (2017) |
Covalent binding | Gold nanoparticle | Au-S bound | Staphylococcal enterotoxin A | 5 ng/ml | Ben Haddada et al. (2017) |
Covalent binding | Gold nanoparticle | Bound between surface alkyne and azido modified proteins | Not available | Not available | Finetti et al. (2016) |
Physical adsorption | Carbon nanoparticle | Not available | β–lactams | 1–30 ng/ml for most antibiotics and 100 ng/ml cephalexin | Zhang X. et al. (2020) |
Covalent binding | Europium III chelate nanoparticle | The binding of the protein did not affect the optical properties | Cystatin C | 24,54 ng/ml | Bian et al. (2022) |
Covalent binding | Latex microparticles | Not available | Bisphenol A | 10 ng/ml | Raysyan and Schneider, (2021) |